US drug launch prices reach $257,000 median amid access barriers
A joint ICER and West Health report found that median US net launch prices reached $257,000 in 2025, while only ...
Tag: ICER
Community Lipid Testing Could Be a Cost-Effective Route to Preventing Cardiovascular Disease
An economic evaluation finds that community-based PocDoc lipid testing in pharmacies, workplaces and homes is cost-effective for identifying people at ...
ICER and West Health Team Up for Annual Report on New Drug Launch Prices and Patient Access
ICER and the West Health Policy Center have announced a partnership to produce an annual Launch Price and Access Report ...
Migraine Pill’s Price Tag Under the Microscope: Atogepant Cost-Effectiveness Tested in Taiwan
A Taiwanese cost-utility analysis finds atogepant's cost-effectiveness for episodic migraine prevention hinges on quality-of-life assumptions and willingness-to-pay thresholds.
-
Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study
-
University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept
-
Bee body mass, pathogens and local climate influence heat tolerance
-
Researchers record first-ever images and data of a shark experiencing a boat strike
-
Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function
Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!